Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Oncology and Therapy
|
November 28, 2024
A Cross-Sectional Study of Variant Interpretation and Reporting of NGS Data Using Tertiary Analysis Software: Navify<sup>®</sup> Mutation Profiler
Francesco Pepe, Gianluca Russo, Nadia Barraco, et al.
Cells
|
October 27, 2022
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer
Annapaola Mariniello, Fabrizio Tabbò, Davide Indellicati, et al.
Cancers
|
January 7, 2021
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer
Caterina De Luca, Francesco Pepe, Antonino Iaccarino, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 11, 2023
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity
Francesca Bersani, Francesca Picca, Deborah Morena, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 15, 2021
RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients
Umberto Malapelle, Francesco Passiglia, Chiara Cremolini, et al.
Personalized Medicine
|
July 8, 2022
RNA-based next-generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center
Caterina De Luca, Francesco Pepe, Pasquale Pisapia, et al.
Diagnostics (Basel, Switzerland)
|
July 27, 2022
Diagnostics of <i>BAP1</i>-Tumor Predisposition Syndrome by a Multitesting Approach: A Ten-Year-Long Experience
Marika Sculco, Marta La Vecchia, Anna Aspesi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 18, 2024
Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA)
Francesco Passiglia, Angela Listì, Paolo Bironzo, et al.
Oncology and Therapy
|
January 10, 2024
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience
Francesco Pepe, Gianluca Russo, Alessandro Venuta, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Oncology and Therapy
|
November 28, 2024
A Cross-Sectional Study of Variant Interpretation and Reporting of NGS Data Using Tertiary Analysis Software: Navify<sup>®</sup> Mutation Profiler
Francesco Pepe, Gianluca Russo, Nadia Barraco, et al.
Cells
|
October 27, 2022
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer
Annapaola Mariniello, Fabrizio Tabbò, Davide Indellicati, et al.
Cancers
|
January 7, 2021
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer
Caterina De Luca, Francesco Pepe, Antonino Iaccarino, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 11, 2023
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity
Francesca Bersani, Francesca Picca, Deborah Morena, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 15, 2021
RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients
Umberto Malapelle, Francesco Passiglia, Chiara Cremolini, et al.
Personalized Medicine
|
July 8, 2022
RNA-based next-generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center
Caterina De Luca, Francesco Pepe, Pasquale Pisapia, et al.
Diagnostics (Basel, Switzerland)
|
July 27, 2022
Diagnostics of <i>BAP1</i>-Tumor Predisposition Syndrome by a Multitesting Approach: A Ten-Year-Long Experience
Marika Sculco, Marta La Vecchia, Anna Aspesi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 18, 2024
Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA)
Francesco Passiglia, Angela Listì, Paolo Bironzo, et al.
Oncology and Therapy
|
January 10, 2024
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience
Francesco Pepe, Gianluca Russo, Alessandro Venuta, et al.
Page
of 4